Artificial enzyme may be first step toward treatment for Parkinson’s disease

New clues to prostate cancer: Why aggressive subtype can resist treatment
5 January 2021
Child physical abuse encounters declined during COVID-19
5 January 2021

Artificial enzyme may be first step toward treatment for Parkinson’s disease

A growing body of research has shown that misshapen and misfolded alpha-synuclein, the protein culprit behind Parkinson’s disease and its characteristics, travels from the gut to the brain, where it spreads and sticks together in lethal clumps known as Lewy bodies. As these clumps accumulate, they cause brain cell death.

Comments are closed.